Pre-Maturity Acquisition and Planned Cancellation of 2nd Series Convertible Bonds


  • The issuer acquired 700 million won (face value) of 2nd series convertible bonds before maturity due to bondholder's exercise of early redemption right.
  • Acquisition amount is 754 million won (own funds), conducted via over-the-counter purchase.
  • Acquired bonds will be cancelled at Korea Securities Depository; remaining face value after acquisition is 2.8 billion won.
  • Conversion price per share adjusted to 3,540 won due to rights offering in 2025.

KOSDAQ Filing Information


  • Filing: Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance
  • Company: Precision Biosensor (335810)
  • Submission: Precision Biosensor Inc.
  • Receipt: 05-15-2026
  • Under KRX KOSDAQ Market Division